» Articles » PMID: 30409781

Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions And...

Overview
Journal Diabetes
Specialty Endocrinology
Date 2018 Nov 10
PMID 30409781
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

In a recent Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study report, mean HbA was the strongest predictor of cardiovascular disease (CVD) after age. In DCCT/EDIC, mean diabetes duration was 6 years (median 4) at baseline and those with high blood pressure or cholesterol were excluded. We now replicate these analyses in the Pittsburgh Epidemiology of Diabetes Complications (EDC) prospective cohort study of childhood-onset (at <17 years of age) type 1 diabetes, with similar age (mean 27 years in both studies) but longer diabetes duration (mean 19 years and median 18 years) and no CVD risk factor exclusion at baseline. CVD incidence (CVD death, myocardial infarction (MI), stroke, revascularization, angina, or ischemic electrocardiogram) was associated with diabetes duration, most recent albumin excretion rate (AER), updated mean triglycerides, baseline hypertension, baseline LDL cholesterol, and most recent HbA Major atherosclerotic cardiovascular events (CVD death, MI, or stroke) were associated with diabetes duration, most recent AER, baseline systolic blood pressure, baseline smoking, and updated mean HbA Compared with findings in DCCT/EDIC, traditional risk factors similarly predicted CVD; however AER predominates in EDC and HbA in DCCT/EDIC. Thus, the relative impact of HbA and kidney disease in type 1 diabetes varies according to diabetes duration.

Citing Articles

A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus.

AlHabeeb W, Elasfar A, Kinsara A, Aljizeeri A, Jelaidan I, Alghalayini K J Saudi Heart Assoc. 2025; 36(4):385-407.

PMID: 39822337 PMC: 11737320. DOI: 10.37616/2212-5043.1407.


Cardiovascular Risk Prediction Scores in Type 1 Diabetes: A Systematic Review and Meta-Analysis.

Erqou S, Shahab A, Fayad F, Haji M, Yuyun M, Joseph J JACC Adv. 2025; 4(1):101462.

PMID: 39801813 PMC: 11719351. DOI: 10.1016/j.jacadv.2024.101462.


Benefits of Camel Milk over Cow and Goat Milk for Infant and Adult Health in Fighting Chronic Diseases: A Review.

Almasri R, Bedir A, Ranneh Y, El-Tarabily K, Al Raish S Nutrients. 2024; 16(22).

PMID: 39599634 PMC: 11597306. DOI: 10.3390/nu16223848.


Predictive markers of early endothelial dysregulation in type-1 diabetes: a meta-analysis.

Mathai M, Alshawsh M, Zulli A, Ranasinghe R Acta Diabetol. 2024; .

PMID: 39527296 DOI: 10.1007/s00592-024-02401-2.


Heterogeneous response of estimated insulin sensitivity indices to metformin in young individuals with type 1 diabetes and different phenotypes.

Ramaldes L, Dos Santos S, Dualib P, de Sa J, Dib S Diabetol Metab Syndr. 2024; 16(1):214.

PMID: 39218890 PMC: 11367792. DOI: 10.1186/s13098-024-01451-4.


References
1.
. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes. 1986; 35(5):530-45. View

2.
Miller R, Anderson S, Costacou T, Sekikawa A, Orchard T . Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study. Diab Vasc Dis Res. 2016; 13(4):250-9. PMC: 5374723. DOI: 10.1177/1479164116629353. View

3.
BUCOLO G, David H . Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973; 19(5):476-82. View

4.
Miller R, Secrest A, Sharma R, Songer T, Orchard T . Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes. 2012; 61(11):2987-92. PMC: 3478551. DOI: 10.2337/db11-1625. View

5.
Prince C, Becker D, Costacou T, Miller R, Orchard T . Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia. 2007; 50(11):2280-8. DOI: 10.1007/s00125-007-0797-7. View